Dual CD33-CLL1-CAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

NCT05016063 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Myeloid, Acute

Interventions

DRUG: Fludarabine
DRUG: Cytoxan
BIOLOGICAL: Dual CD33-CLL1 CAR-T cells

Sponsor

Xinqiao Hospital of Chongqing

Collaborators

[object Object]